Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Cytodyn Inc (OP:CYDY)

0.2424 UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EST, Feb 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.2424
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.2424
Today's Range 0.2424 - 0.2424
52wk Range 0.1865 - 0.4945
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer
From CytoDyn Inc.
Via GlobeNewswire
News headline image
December 2025 Letter to Shareholders
From CytoDyn Inc.
Via GlobeNewswire

Performance

YTD
-10.3%
-10.3%
1 Month
-16.4%
-16.4%
3 Month
-2.0%
-2.0%
6 Month
-7.5%
-7.5%
1 Year
+21.9%
+21.9%

More News

Read More
News headline image
CytoDyn to Showcase PD-L1 Upregulation and Improved Survival in Metastatic Triple Negative Breast Cancer at the San Antonio Breast Cancer Symposium
From CytoDyn Inc.
Via GlobeNewswire
News headline image
A Penny Stock To Watch In Challenging Cancer Space ↗
Via Benzinga
News headline image
CytoDyn Announces Resolution of Class Action Lawsuit
From CytoDyn Inc.
Via GlobeNewswire
News headline image
CytoDyn to Present Prolonged Survival Data on Leronlimab in Metastatic Triple-Negative Breast Cancer at the San Antonio Breast Cancer Symposium
From CytoDyn Inc.
Via GlobeNewswire
News headline image
CytoDyn Secures $30 Million Commitment from Yorkville Advisors
From CytoDyn Inc.
Via GlobeNewswire
News headline image
Halper Sadeh LLC Encourages CytoDyn Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
CytoDyn to Present at the LD Micro Main Event XIX Investor Conference
From CytoDyn Inc.
Via GlobeNewswire
News headline image
September 2025 Letter to Shareholders
From CytoDyn Inc.
Via GlobeNewswire
News headline image
CytoDyn to Present on Leronlimab Induction of PD-L1 and Immune Checkpoint Inhibitor Responses in Metastatic Triple-Negative Breast Cancer at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity
From CytoDyn Inc.
Via GlobeNewswire
News headline image
CytoDyn to Present at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity
From CytoDyn Inc.
Via GlobeNewswire
News headline image
CytoDyn Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
From CytoDyn Inc.
Via GlobeNewswire
News headline image
CytoDyn to Present at the H.C. Wainwright 27th Annual Global Investment Conference
From CytoDyn Inc.
Via GlobeNewswire
News headline image
CytoDyn Announces Encouraging Survival Data in Patients with Metastatic Colorectal Cancer Previously Treated with Leronlimab
From CytoDyn Inc.
Via GlobeNewswire
News headline image
CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer
From CytoDyn Inc.
Via GlobeNewswire
News headline image
CytoDyn Releases ESMO Breast Cancer Meeting Poster
From CytoDyn Inc.
Via GlobeNewswire
News headline image
CytoDyn Announces Data Suggesting Novel Mechanism of Action of Leronlimab for the Treatment of Solid Tumors
From CytoDyn Inc.
Via GlobeNewswire
News headline image
CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer
From CytoDyn Inc.
Via GlobeNewswire
News headline image
CytoDyn Leadership Team To Attend ESMO Breast Cancer Meeting in Munich, Germany
From CytoDyn Inc.
Via GlobeNewswire
News headline image
When Penny Stocks Can Become Compelling: A Long-Term Buy With CYDY ↗
Via Talk Markets
Topics Stocks / Equities
News headline image
FDA Advisory Committee Shakeup and Implications for Capricor Therapeutics ↗
Via Talk Markets
Topics Government Stocks / Equities
News headline image
March 2025 Letter to Shareholders
From CytoDyn Inc.
Via GlobeNewswire
News headline image
CytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with Leronlimab
From CytoDyn Inc.
Via GlobeNewswire
News headline image
CytoDyn Announces Findings of Statistically Significant Fibrosis Reversal Across Studies with SMC Laboratories
From CytoDyn Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Cytodyn Inc publicly traded?
Yes, Cytodyn Inc is publicly traded.
What exchange does Cytodyn Inc trade on?
Cytodyn Inc trades on the OTC Traded
What is the ticker symbol for Cytodyn Inc?
The ticker symbol for Cytodyn Inc is CYDY on the OTC Traded
What is the current price of Cytodyn Inc?
The current price of Cytodyn Inc is 0.2424
When was Cytodyn Inc last traded?
The last trade of Cytodyn Inc was at 02/03/26 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.